Somerville v. State: No Plain Error for Implied Confrontation-Clause Testimony and “Slip-of-the-Tongue” Jury Instructions Cured by the Written Charge 1. Introduction In Somerville v. State (Supreme...
Edwards v. State (Ga. 2026): Ineffective-Assistance Claims Are Barred on Appeal When Not Raised (and Explicitly Disclaimed) at the Motion-for-New-Trial Stage Introduction In Edwards v. State, the...
Rule 403 Admissibility of Social-Media Gun Imagery to Prove Access to Distinctive Weapon Features (Laser/Sight) and Strickland No-Prejudice for Omitted Identification Charges 1. Introduction In...
Mootness Risk Is Only a Factor in Rule 54(b) Certification; Monell Liability Requires Specific, Similar Patterns and Causation 1. Introduction Aaron Davis v. Tyler W.A. Duncan (6th Cir. Aug. 13,...
Unpaid Domestic Servitude as “Harboring for Private Financial Gain”: Intent to Shield Inferred from Coercive Control, and Credibility Attacks Rarely Defeat Sufficiency 1. Introduction United States...
Post-Release “Registration” Orders Are Unauthorized Absent a Term of Supervised Release United States v. Jerid Hinz (7th Cir. Aug. 13, 2026) 1. Introduction In United States v. Jerid Hinz, the...
Gray-Market Prescription Drugs: “Material Differences” and Quality-Control Bypass Render Foreign-Labeled Medicines Non-Genuine Under the Lanham Act; Contributory Liability Requires Knowledge (Not...
Sixth Circuit: No § 2255 Evidentiary Hearing Where the Record Forecloses Prejudice from Alleged Misadvice on a Physician’s Good-Faith Defense Under 21 U.S.C. § 841(a) I. Introduction In Afzal Beemath...
Defective Trustee Substitution Goes to Capacity—Not Article III Standing—and May Be Cured by Waiver/Ratification 1. Introduction In UMB Bank, N.A. v. Bristol-Myers Squibb Company (2d Cir. Aug. 13,...
Fourth Circuit Reaffirms Plain-Error Review of Unpreserved Rule 11/32 Claims and Presumptive Reasonableness of Within-Guidelines Sentences in Anders Appeals 1. Introduction In United States v. John...
Reverse-Payment Antitrust Standing Requires Proof FDA Approval Would Have Occurred Earlier (Not Merely Could Have) Case: In re: Lipitor Antitrust Litigation (3d Cir. Aug. 13, 2026) (Not Precedential)...
§ 1983 Facial Challenges to Illinois Post-Conviction DNA Testing: Standing Against the Prosecutor and No Rooker-Feldman Bar 1. Introduction In Reginald Chapman v. Eileen O'Neill Burke (7th Cir. Aug....
People v. Shove: Hybrid Batson/Wheeler Review Permits Stage-One Analysis for an Unexplained Strike While Applying Stage-Three Review to Other Explained Strikes 1. Introduction People v. Shove (Cal....
Plain-Error Limits on “Stand Your Ground” and Reconstituted-Jury Instructions After Alternate Substitution Case: Sanders v. State (Supreme Court of Georgia, Aug. 13, 2026) Core takeaway: Absent...
United States v. Matos: The Second Circuit Adopts Hunter’s “Miscarriage of Justice” Exception to Appeal Waivers—But Holds Routine Guidelines Disputes Still Waived; Standing-Order Incorporation...
Ex Parte Buccal-Swab DNA Warrants: No Pre-Issuance Hearing Required, and Probable Cause Need Not Identify a Viable Comparison Sample 1. Introduction United States v. Leeper (2d Cir. Aug. 13, 2026)...
Fourth Circuit: Foreign-Market Prescription Drugs Are “Non-Genuine” Gray-Market Goods When Labeling/Regulatory Disclosures and Distribution Quality Controls Materially Differ; Contributory Lanham...
Illinois Reliance-Based Estoppel Limits Nonsignatory Arbitration: “Direct Benefits Estoppel” Rejected Absent Detrimental Reliance 1. Introduction Sunco International Inc. v. Jiangsu Sunco Boiler Co.,...
Rule 54’s 14-Day Deadline Bars Late Requests for Appellate Fees Absent an Express Court Order 1. Introduction In Merchant v. Merchant (5th Cir. Aug. 13, 2026) (per curiam) (not designated for...
FDCA Does Not Preclude Lanham Act Gray‑Market Drug Claims; Contributory Infringement Knowledge Requires No Prior Notice 1. Introduction Case: Gilead Sciences, Inc. v. ProAct, Inc. (consolidated...